A randomized controlled trial for hydroxychloroquine sulfate in the treatment of idiopathic membranous nephropathy A randomized controlled trial for hydroxychloroquinesulfate in the treatment of idiopathic membranou ...
The efficacy and safety of hydroxychloroquine sulfate in idiopathic membranous nephropathy: A randomized, controlled, Single-center clinical trial The efficacy and safety of hydroxychloroquinesulfate in idiopathic membranous nephropathy: A randomi ...
Idiopathic Membranous Nephropathy
Group 1:Supportive treatment+Perindopril 8 mg/day;Group 2:Supportive treatment+Perindopril 8 mg/day+hydroxychloroquinesulfate (200mg 2/d);Group 3:Low dose glucocorticoid (0.5mg/kg.d)+cyclosporine A (valley concentration controlled at 50-100ng/ml);Group 4:Low dose glucocorticoid (0.5mg/kg.d)+cyclosporine A (valley concentration controlled at 50-100ng/ml)+hydroxychloroquinesulfate (200mg 2/d); Group 1:Supportive treatment+Perindopril8 mg/day;Group 2:Supportive treatment+Perindopril8 mg/day+hy ...
Nephrology Division, First Hospital Affiliated to Army Medical University